§ Funding Round
Series B funding round for Evozyne raising $81M in September 2023
Series B funding round for Evozyne raising $81M in September 2023
| Investor | Firm Type | Partner |
|---|---|---|
| Organization | — | |
| Organization | — | |
| Organization | — | |
OrbiMedLEAD | Organization | — |
| Organization | — | |
| Organization | — | |
| Angel | ted driscoll | |
Fidelity Management & Research CompanyLEAD | — | — |
| Organization | — | |
Paragon Biosciences | — | — |
| Organization | — |
This company has completed 1 funding round. Current round is highlighted.
Total Raised
$81M
Top Valuation
-
Evozyne raised $81M in a Series B round.
The round was announced on 09/01/23.
The round was led by OrbiMed, Fidelity Management & Research Company.
